Ignite Creation Date:
2025-12-24 @ 9:29 PM
Ignite Modification Date:
2026-05-28 @ 3:31 AM
Study NCT ID:
NCT06140732
Status:
RECRUITING
Last Update Posted:
2023-11-20
First Post:
2023-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma
Sponsor:
Xuanwu Hospital, Beijing
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XW-NS-ACCFC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None